ANGO

AngioDynamics to Present at Upcoming Investor Conferences

[GlobeNewswire] – ALBANY, N.Y. — AngioDynamics , a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today the company … moreView todays social media effects on ANGOView the latest stocks trending across Twitter. Click to view dashboardSee who AngioDynamics is hiring next, click here to view […]

AngioDynamics’ CEO Discusses F3Q2014 Results – Earnings Call Transcript

[at Seeking Alpha] – Joseph M. DeVivo Thank you, Bob. Welcome ladies and gentlemen to our third quarter AngioDynamics conference call. I’m very pleased to report a very strong revenue performance for the entire AngioDynamics … moreView todays social media effects on ANGOView the latest stocks trending across Twitter. Click to view dashboardSee who AngioDynamics is hiring next, click here […]

4:03 pm AngioDynamics updates U.S. tip location strategy; co acquires rights to Celebrity System, including next-generation navigation technology

moreView todays social media effects on ANGOView the latest stocks trending across Twitter. Click to view dashboardSee who AngioDynamics is hiring next, click here to view […]

AngioDynamics to Present at the Barclays Global Healthcare Conference

[at noodls] – ALBANY, N.Y., March 3, 2014 (GLOBE NEWSWIRE) — AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease … moreView todays social media effects on ANGOView the latest stocks trending across Twitter. Click to view dashboardSee who AngioDynamics is hiring next, click here to view […]

Why Cynosure (CYNO) Has A Bright Short-Term Future?

moreView todays social media effects on ANGOView the latest stocks trending across Twitter. Click to view dashboardSee who AngioDynamics is hiring next, click here to view […]

AngioDynamics Reports Fiscal 2013 Third Quarter Financial Results

[at noodls] – Net sales of $81.6 million GAAP net loss of $0.03 per share; Adjusted (Non-GAAP) net income of $0.08 per share Adjusted EBITDA of $12.7 million, or $0.37 per share; 54% growth over Q3 FY12 Operating cash … moreView todays social media effects on ANGOView the latest stocks trending across Twitter. Click to view dashboardSee who AngioDynamics is […]

AngioDynamics to Report Fiscal 2013 Third Quarter Financial Results and Hold Conference Call on April 8, 2013

[at noodls] – ALBANY, N.Y., March 27, 2013 (GLOBE NEWSWIRE) — AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease … moreView todays social media effects on ANGOView the latest stocks trending across Twitter. Click to view dashboardSee who AngioDynamics is hiring next, click here to view […]

AngioDynamics to Present at Barclays Global Healthcare Conference

[at noodls] – ALBANY, N.Y., March 8, 2013 (GLOBE NEWSWIRE) — AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease … moreView todays social media effects on ANGOView the latest stocks trending across Twitter. Click to view dashboardSee who AngioDynamics is hiring next, click here to view […]